• 1
    Akbar, A.N., Salmon, M., Janossy, G. (1991) The synergy between naive and memory T cells during activation. Immunology Today, 12, 184 188.
  • 2
    Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473 476.
  • 3
    Chaudhary, P.M., Mechetner, E.B., Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735 2739.
  • 4
    Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85 94.
  • 5
    Chong, A.S., Markham, P.N., Gebel, H.M., Bines, S.D., Coon, J.S. (1993) Diverse multidrug resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunology and Immunotherapy, 36, 133 139.
  • 6
    Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M., Huber, H. (1996) Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood, 88, 1747 1754.
  • 7
    Feller, N., Kuiper, C.M., Lankelma, J., Ruhdal, J.K., Scheper, R.J., Pinedo, H.M., Broxterman, H.J. (1995) Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. British Journal of Cancer, 72, 543 549.
  • 8
    Fox, B., Lewis, D., Deemer, K., El Masry, M., Rich, R. (1987) T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes. Journal of Experimental Medicine, 166, 404 418.
  • 9
    Goasguen, J.E., Dossot, J.M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P.Y., Chaperon, J., Fuachet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394 2398.
  • 10
    Gottesman, M.M., Willingham, M.C., Thiebaut, F., Pastan, I. (1991) Expression of the MDR1 gene in normal human tissue. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press, New York.
  • 11
    Gros, P., Croop, J., Housman, D. (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47, 371 380.
  • 12
    Gupta, S., Choong, H.K., Tsuruo, T., Gollapudi, S. (1992) Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. Journal of Clinical Immunology, 12, 451 458.
  • 13
    Hofman, J., Ueberall, F., Egle, A., Grunicke, H. (1991) B-859-35 a new drug with anti-tumor activity reverses multi-drug resistance. International Journal of Cancer, 47, 870 874.
  • 14
    Hollt, V., Kouba, M., Dietel, M., Vogt, G. (1992) Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-gp. Biochemical Pharmacology, 43, 2601 2608.
  • 15
    Johannisson, A. & Festin, R. (1995) Phenotype transition of CD4+ T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry, 19, 343 352.
  • 16
    Klimecki, W.T., Futscher, B.W., Grogan, T.M., Dalton, W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 2451 2458.
  • 17
    Kobayashi, Y., Yamashiro, T., Watanabe, N., Tanaka, H., Shigenobu, H., Tsuruo, T. (1994) Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell population revealed by MRK-16 monoclonal antibody and AHC-52. Biochemical Pharmacology, 48, 1641 1646.
  • 18
    Ludescher, C., Eisterer, W., Hilbe, W., Gotwald, M., Hofmann, J., Zabernigg, A., Cianfriglia, M., Thaler, J. (1995a) Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Leukemia, 9, 350 356.
  • 19
    Ludescher, C., Eisterer, W., Hilbe, W., Hofman, J., Thaler, J. (1995b) Decreased potency of MDR-modulators under serum conditions determined by a functional assay. British Journal of Haematology, 91, 652 657.
  • 20
    Ludescher, C., Hilbe, W., Eisterer, W., Preuss, E., Huber, C., Gotwald, M., Hofmann, J., Thaler, J. (1993) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. Journal of the National Cancer Institute, 85, 1751 1758.
  • 21
    Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H., Hofmann, J. (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. British Journal of Haematology, 82, 161 168.
  • 22
    Mackay, C.R. (1991) T-cell memory: the connection between function, phenotype and migration pathways. Immunology Today, 12, 189 192.
  • 23
    Nooter, K. & Sonneveld, P. (1994) Clinical relevance of P-glycoprotein in hematological malignancies. Leukemia Research, 18, 233 243.
  • 24
    Pastan, I. & Gottesman, M. (1987) Multiple-drug resistance in human cancer. New England Journal of Medicine, 316, 1388 1393.
  • 25
    Picker, L.J., Singh, M.K., Zdraveski, Z., Treer, J.R., Waldrop, S.L., Berstresser, P.R., Maino, C. (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood, 86, 1408 1419.
  • 26
    Robertson, M.J. & Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood, 76, 2421 2438.
  • 27
    Rubbert, A., Manger, B., Lang, N., Kalden, J.R., Platzer, E. (1991) Functional characterization of tumor-infiltrating lymphocytes, lymph node lymphocytes and peripheral blood lymphocytes from patients with breast cancer. International Journal of Cancer, 49, 25 31.
  • 28
    Tajima, F., Kawatani, T., Endo, A., Kawasaki, H. (1996) Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia. Leukemia, 10, 478 482.
  • 29
    Trowbridge, I.S. & Thomas, M.L. (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annual Review of Immunology, 12, 85 116.
  • 30
    Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., Hori, R. (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. Journal of Biological Chemistry, 34, 24248 24252.
  • 31
    Weinstein, R.S., Kuszak, J.R., Kluskens, L.F., Coon, J.S. (1990) P-glycoprotein in pathology: the multidrug resistance gene family in humans. Human Pathology, 21, 34 48.
  • 32
    Yuen, A.R. & Sikic, B.I. (1994) Multidrug resistance in lymphomas. Journal of Clinical Oncology, 12, 2453 2460.